Two Dimensional Versus Three Dimensional Transvaginal U/S With or Without SIS
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Primary aim: To assess the diagnostic agreement between 2D vs 3D TV U/S with or without SIS for the evaluation of cesarean scar defects and its correlation with symptoms. Secondary aims: To assess the relation between the size of the niche and the patient symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2026
CompletedFirst Posted
Study publicly available on registry
July 15, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
July 15, 2026
July 1, 2026
5 months
July 9, 2026
July 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic agreement between 3D-TVUS and SIS in detecting cesarean scar defects, assessed using Cohen's kappa coefficient
1 hour
Study Arms (1)
scar niche patients
Eligibility Criteria
women aged 20-45 years History of at least one previous cesarean section Interval since last cesarean section ranging from 6 months to 10 years Willingness to participate and provide written informed consent
You may qualify if:
- Women aged 20-45 years
- History of at least one previous cesarean section
- Interval since last cesarean section ranging from 6 months to 10 years
- Willingness to participate and provide written informed consent
You may not qualify if:
- Current pregnancy
- Active pelvic infection or acute pelvic inflammatory disease
- Large uterine fibroids distorting the uterine cavity
- History of uterine surgery other than cesarean section (e.g., myomectomy)
- Failure of SIS performance
- Patients on any contraception methods
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Emam Mohamed Sayed
Study Record Dates
First Submitted
July 9, 2026
First Posted
July 15, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
July 15, 2026
Record last verified: 2026-07